JAYSON PAULO AGATON: Open Payments
NPI 1255761391 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
Products named: ARISTADA, CAPLYTA, SPRAVATO, LUMRYZ, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
